A shear gradient-activated microfluidic device for automated monitoring of whole blood haemostasis and platelet function
Open accessThe DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
Accurate assessment of blood haemostasis is essential for the management of patients who use extracorporeal devices, receive anticoagulation therapy or experience coagulopathies. However, current monitoring devices do not measure effects of haemodynamic forces that contribute significantly to platelet function and thrombus formation. Here we describe a microfluidic device that mimics a network of stenosed arteriolar vessels, permitting evaluation of blood clotting within small sample volumes under pathophysiological flow. By applying a clotting time analysis based on a phenomenological mathematical model of thrombus formation, coagulation and platelet function can be accurately measured in vitro in patient blood samples. When the device is integrated into an extracorporeal circuit in pig endotoxemia or heparin therapy models, it produces real-time readouts of alterations in coagulation ex vivo that are more reliable than standard clotting assays. Thus, this disposable device may be useful for personalized diagnostics and for real-time surveillance of antithrombotic therapy in clinic.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Microfluidic perfusion models that are used to model early stage atherosclerosis and later thrombosis have a significant potential in drug development [291–294].”
From Cardiovascular disease models: A game changing paradigm in drug discovery and screening (2019) · cites this paper as [293]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rapid Prototyping of Microfluidic Systems in Poly(dimethylsiloxane)
Duffy, D. C., McDonald, J. C., Schueller, O. J. A., & Whitesides, G. M. (1998) · Analytical Chemistry · doi:10.1021/ac980656z · Cited by 5,288 · cited 7×
“( c ) Photograph of three haemostasis monitoring devices formed in a single piece of PDMS mould on top of a standard glass slide (75 (cid:4) 50mm).”
MethodInfluentialA shear gradient–dependent platelet aggregation mechanism drives thrombus formation
Nesbitt, W. S., Westein, E., Tovar-Lopez, F. J., Tolouei, E., Mitchell, A., Fu, J., Carberry, J., Fouras, A., & Jackson, S. P. (2009) · Nature Medicine · doi:10.1038/nm.1955 · Cited by 862 · cited 3×
“Notably, flow acceleration and deceleration (fluid shear gradients) have been shown to initiate platelet aggregation during arterial thrombosis in vivo 14,15 , and clotting in extracorporeal devices usually occurs at sites of sudden flow disturbances, stagnation points and stenosed sections of tubing…”
Animal Models of sepsis: setting the stage
Buras, J. A., Holzmann, B., & Sitkovsky, M. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1854 · Cited by 843 · cited 1×
“…by intravenous infusion of lipopolysaccharide (LPS) are widely used to study disruption of haemostasis and intravascular coagulation owing to sepsis 33 Therefore, we first injected a lethal dose of LPS intravenously to the pig for 90 min and then monitored the coagulation state of the animal’s…”
Cho, Y. I., & Kensey, K. R. (1991) · Biorheology · doi:10.3233/bir-1991-283-415 · Cited by 823
A bioinspired omniphobic surface coating on medical devices prevents thrombosis and biofouling
Leslie, D. C., Waterhouse, A., Berthet, J. B., Valentin, T. M., Watters, A. L., Jain, A., Kim, P., Hatton, B. D., Nedder, A., Donovan, K., et al. (2014) · Nature Biotechnology · doi:10.1038/nbt.3020 · Cited by 758 · cited 2×
“When the blood was filled in a syringe and pushed, the syringe was manually agitated every 2–3min to prevent sedimentation of erythrocytes in the blood.”
Self-citationMicro- and Nanoscale Fluid Mechanics: Transport in Microfluidic Devices
Kirby, B. J. (2010) · Cited by 753
The growing complexity of platelet aggregation
Jackson, S. P. (2007) · Blood · doi:10.1182/blood-2006-12-027698 · Cited by 737 · cited 1×
“As platelet aggregation is a major contributor to the development of vascular occlusion, 29 we further explored if this biomimetic device can be used as a rapid platelet function assay under stenosed flow.”
Ganter, M. T., & Hofer, C. K. (2008) · Anesthesia & Analgesia · doi:10.1213/ane.0b013e318168b367 · Cited by 677
Hirsh, J., Dalen, J. E., Deykin, D., & Toller, L. (1992) · Chest · doi:10.1378/chest.102.4_supplement.337s · Cited by 558 · cited 2×
“4f) 26 .”
BackgroundExtracorporeal Membrane Oxygenation—Hemostatic Complications
Murphy, D. A., Hockings, L. E., Andrews, R. K., Aubron, C., Gardiner, E. E., Pellegrino, V. A., & Davis, A. K. (2015) · Transfusion Medicine Reviews · doi:10.1016/j.tmrv.2014.12.001 · Cited by 455
Hirsh, J., Raschke, C. R., Warkentin, T. E., Dalen, J. E., Deykin, D., & Poller, L. (1995) · Chest · doi:10.1378/chest.108.4_supplement.258s · Cited by 394
Guidelines for the laboratory investigation of heritable disorders of platelet function
Harrison, P., Mackie, I., Mumford, A., Briggs, C., Liesner, R., Winter, M., Machin, S., & British Committee for Standards in Haematology (2011) · British Journal of Haematology · doi:10.1111/j.1365-2141.2011.08793.x · Cited by 391 · cited 1×
“…do not detect the platelet defect in HPS patients, and neither these methods nor platelet aggregometry are recommended as a first line clinical test for this syndrome; as a result, time consuming and specialized electron microscopy is still required for an unequivocal diagnosis at this time 30 .”
Kullo, I. J., & Rooke, T. W. (2016) · New England Journal of Medicine · doi:10.1056/nejmcp1507631 · Cited by 333
Platelet Function Testing in Cardiovascular Diseases
Michelson, A. D. (2004) · Circulation · doi:10.1161/01.cir.0000147228.29325.f9 · Cited by 317 · cited 1×
“Equations (2) and (3) lead to an exponential growth curve (reciprocal of sigmoid) for pressure, of the form”
Westein, E., van der Meer, A. D., Kuijpers, M. J. E., Frimat, J.-P., van den Berg, A., & Heemskerk, J. W. M. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1209905110 · Cited by 304 · cited 3×
“…after collagen coating, we still observed larger amounts of fibrin and platelet aggregates in the post-stenosed regions, which is consistent with past findings suggesting that the shear rate gradient in the decelerating flow region may be a major contributor to the haemostatic response 14,15 (Fig.”
Role of high shear rate in thrombosis
Casa, L. D. C., Deaton, D. H., & Ku, D. N. (2015) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2014.12.050 · Cited by 295
Common risk factors for both arterial and venous thrombosis
Lowe, G. D. O. (2008) · British Journal of Haematology · doi:10.1111/j.1365-2141.2007.06973.x · Cited by 190 · cited 2×
“Because current haemostasis tests used in the clinic do not incorporate the physiological contributions of haemodynamic shear stresses and gradients 27 , we explored whether we can detect changes in clotting times in response to pathophysiological variations in shear rates and gradients in our…”
Son, Y. (2007) · Polymer · doi:10.1016/j.polymer.2006.11.048 · Cited by 168 · cited 2×
“The wall shear stress/rate corresponding to the imposed flow rate at the uniform width region was determined from analytical formulae derived for rectangular microchannels 24 and shear gradients at the pre-stenosed and post-stenosed regions were predicted from computational analysis.”
BackgroundMethodHOSOKAWA, K., OHNISHI, T., KONDO, T., FUKASAWA, M., KOIDE, T., MARUYAMA, I., & TANAKA, K. A. (2011) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2011.04464.x · Cited by 160
Extracorporeal life support: the precarious balance of hemostasis
Annich, G. M. (2015) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12963 · Cited by 158
Fogelson, A. L., & Tania, N. (2005) · Pathophysiology of Haemostasis and Thrombosis · doi:10.1159/000089930 · Cited by 128 · cited 1×
“…behaviour under static (no flow) or irrelevant flow conditions, and thus, they fail to incorporate the effects of haemodynamic forces (pressure, flow and shear stress) and related cellular interactions that are known to significantly impact whole blood thrombosis in the living vasculature 3,13 .”
BackgroundPeripheral artery disease. Part 1: clinical evaluation and noninvasive diagnosis
Lau, J. F., Weinberg, M. D., & Olin, J. W. (2011) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2011.66 · Cited by 111 · cited 1×
“…the stenosed region in our device, and determined that it corresponds to a shear change equivalent to that produced when the diameter of an arteriole decreases from B 275 to 125 m m ( j ) or B 55% stenosis, which is typically seen clinically, for example, in patients with arterio-sclerosis 8,24 .”
Microfluidic Thrombosis under Multiple Shear Rates and Antiplatelet Therapy Doses
Li, M., Hotaling, N. A., Ku, D. N., & Forest, C. R. (2014) · PLoS ONE · doi:10.1371/journal.pone.0082493 · Cited by 104 · cited 1×
“…parallel plate flow chambers that mimic atherosclerotic confinement of vessels and reconstitute physiological shear rates and gradients have been developed for basic research studies using human whole blood in combination with extracellular matrix (for example, collagen) surface coatings 15,18,19 .”
Role of coagulation testing in predicting bleeding risk
Chee, Y., & Greaves, M. (2003) · The Hematology Journal · doi:10.1038/sj.thj.6200306 · Cited by 101
Bajaj, S. P., & Joist, J. H. (1999) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-2007-994943 · Cited by 98
Tests of global haemostasis and their applications in bleeding disorders
Nair, S. C., Dargaud, Y. G., Chitlur, M., & Srivastava, A. (2010) · Haemophilia · doi:10.1111/j.1365-2516.2010.02304.x · Cited by 87 · cited 1×
“Moreover, the requirement for monitoring haemostasis reliably at the bedside using low blood volumes is even more critical in paediatric patients with acute coagulopathy (acquired or congenital), as they are more vulnerable than adults 7–9 .”
Neeves, K. B., Onasoga, A. A., Hansen, R. R., Lilly, J. J., Venckunaite, D., Sumner, M. B., Irish, A. T., Brodsky, G. L., Manco‐Johnson, M. J., & Paola, J. A. D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054680 · Cited by 83 · cited 1×
“20 This reduced the microfluidic clotting time significantly ( P o 0.05; multiple t -tests), thereby enabling us to use the device to perform clotting analysis in a few minutes using o 1 ml of human whole blood (Fig.”
MethodInfluentialSharda, A. V., Kim, S. H., Jasuja, R., Gopal, S., Flaumenhaft, R. C., Furie, B. C., & Furie, B. (2015) · Blood · doi:10.1182/blood-2014-08-597419 · Cited by 83 · cited 1×
“This observation also inspired us to explore if occlusion in this device is dependent on the release of ADP agonist 31,32 from platelet dense granules, which are dysfunctional in HPS patients.”
Self-citationAssays of different aspects of haemostasis – what do they measure?
Tynngård, N., Lindahl, T. L., & Ramström, S. (2015) · Thrombosis Journal · doi:10.1186/s12959-015-0036-2 · Cited by 83 · cited 1×
“Equations (2) and (3) lead to an exponential growth curve (reciprocal of sigmoid) for pressure, of the form”
Anticoagulation in Chronic Hemodialysis: Progress Toward an Optimal Approach
Kessler, M., Moureau, F., & Nguyên, P. (2015) · Seminars in Dialysis · doi:10.1111/sdi.12380 · Cited by 80 · cited 1×
“…oxygenation, mechanical circulatory support, and so on) require precise and personalized anticoagulation dose monitoring on as close to real-time basis as possible to maintain haemostasis in vivo , and to prevent clotting in the blood transport lines and pumps of these devices ex vivo 4,5 .”
Microfluidic technology as an emerging clinical tool to evaluate thrombosis and hemostasis
Branchford, B. R., Ng, C. J., Neeves, K. B., & Paola, J. D. (2015) · Thrombosis Research · doi:10.1016/j.thromres.2015.05.012 · Cited by 77
In Vivo Fluorescence Imaging of Large-Vessel Thrombosis in Mice
Cooley, B. C. (2011) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.225334 · Cited by 75 · cited 1×
“Based on the previous studies showing that the size of a growing thrombus measured in vitro correlates linearly with measured light intensity 41,42 , we can approximate that A max ¼ Sig ð t Þ , where A (t) is the cross-sectional area available for blood flow through the occluding channel at a given…”
BackgroundPlatelets and Atherothrombosis: Causes, Targets and Treatments for Thrombosis
Siddiqui, T., S., A. K., & Dikshit, D. K. (2013) · Current Medicinal Chemistry · doi:10.2174/0929867311320220004 · Cited by 62
Surveillance of Hemodialysis Vascular Access
Whittier, W. L. (2009) · Seminars in Interventional Radiology · doi:10.1055/s-0029-1222457 · Cited by 61 · cited 1×
“…evolution of blood clots can be recorded and quantified easily using just a blood pump, a disposable pressure sensor and a display monitor (imaging equipment is optional), all of which are also part of most extracorporeal circuits and hence, currently used widely in medical settings 35,36 .”
Management of anticoagulation and hemostasis for pediatric extracorporeal membrane oxygenation.
Saini, A., & Spinella, P. (2014) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2014.06.014 · Cited by 57 · cited 1×
“Moreover, the requirement for monitoring haemostasis reliably at the bedside using low blood volumes is even more critical in paediatric patients with acute coagulopathy (acquired or congenital), as they are more vulnerable than adults 7–9 .”
Meyer, A. D. J., Wiles, A. A., Rivera, O., Wong, E. C. C., Freishtat, R. J., Rais-Bahrami, K., & Dalton, H. J. (2012) · Pediatric Critical Care Medicine · doi:10.1097/pcc.0b013e31823c98ef · Cited by 57 · cited 1×
“…flow acceleration and deceleration (fluid shear gradients) have been shown to initiate platelet aggregation during arterial thrombosis in vivo 14,15 , and clotting in extracorporeal devices usually occurs at sites of sudden flow disturbances, stagnation points and stenosed sections of tubing 16,17 .”
BackgroundPoint‐of‐care monitoring of haemostasis
Mallett, S., & Armstrong, M. (2014) · Anaesthesia · doi:10.1111/anae.12909 · Cited by 56 · cited 1×
“6), and therefore, for simplicity and to reduce one dimension from the equation (4), we assume k to be unity, which leads to the approximation that the rise in pressure drop of an occluding microchannel follows a two-parameter exponential growth curve described in equation (1).”
HOLM, H. A., Abildgaard, U., & Kalvenes, S. (1985) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1661293 · Cited by 55
Monitoring in vitro thrombus formation with novel microfluidic devices
Westein, E., de Witt, S., Lamers, M., Cosemans, J. M. E. M., & Heemskerk, J. W. M. (2012) · Platelets · doi:10.3109/09537104.2012.709653 · Cited by 54
Biomimetic postcapillary expansions for enhancing rare blood cell separation on a microfluidic chip
Jain, A., & Munn, L. L. (2011) · Lab on a Chip · doi:10.1039/c1lc20401g · Cited by 54 · cited 1×
“To describe the stress-strain relationship and blood viscosity, a generalized power-law constitutive equation for non-Newtonian fluids was applied and parameters were chosen based on published values 39,40 .”
MethodSelf-citationSchöchl, H., Solomon, C., Schulz, A., Voelckel, W., Hanke, A., van Griensven, M., Redl, H. R., & Bahrami, S. (2010) · Molecular Medicine · doi:10.2119/molmed.2010.00159 · Cited by 49
Effect of specimen collection on routine coagulation assays and D-dimer measurement
Lippi, G., & Guidi, G. C. (2004) · Clinical Chemistry · doi:10.1373/clinchem.2004.036244 · Cited by 39
A low-volume, single pass in-vitro system of high shear thrombosis in a stenosis
Para, A. N., & Ku, D. N. (2013) · Thrombosis Research · doi:10.1016/j.thromres.2013.02.018 · Cited by 26 · cited 2×
“…parallel plate flow chambers that mimic atherosclerotic confinement of vessels and reconstitute physiological shear rates and gradients have been developed for basic research studies using human whole blood in combination with extracellular matrix (for example, collagen) surface coatings 15,18,19 .”
Bell, D. N., Spain, S., & Goldsmith, H. L. (1989) · Biophysical Journal · doi:10.1016/s0006-3495(89)82729-8 · Cited by 25 · cited 1×
“This observation also inspired us to explore if occlusion in this device is dependent on the release of ADP agonist 31,32 from platelet dense granules, which are dysfunctional in HPS patients.”
BackgroundExtracorporeal circuit pressure profiles during continuous venovenous haemofiltration
Ejaz, A. A., Komorski, R. M., Ellis, G. H., & Munjal, S. (2007) · Nursing in Critical Care · doi:10.1111/j.1478-5153.2006.00192.x · Cited by 24 · cited 1×
“…evolution of blood clots can be recorded and quantified easily using just a blood pump, a disposable pressure sensor and a display monitor (imaging equipment is optional), all of which are also part of most extracorporeal circuits and hence, currently used widely in medical settings 35,36 .”
BackgroundStephens, G., He, M.-S., Wong, C. H. Y., Jurek, M., Luedemann, H.-C., Shapurian, G., Munnelly, K., Muir, C., Conley, P. B., Phillips, D. R., et al. (2012) · Thrombosis Journal · doi:10.1186/1477-9560-10-11 · Cited by 14 · cited 1×
“…on the previous studies showing that the size of a growing thrombus measured in vitro correlates linearly with measured light intensity 41,42 , we can approximate that A max ¼ Sig ð t Þ , where A (t) is the cross-sectional area available for blood flow through the occluding channel at a given…”
Severe Clotting During Extracorporeal Dialysis Procedures
Boyer, C. J., & Swartz, R. D. (1991) · Seminars in Dialysis · doi:10.1111/j.1525-139x.1991.tb00417.x · Cited by 13 · cited 1×
“…flow acceleration and deceleration (fluid shear gradients) have been shown to initiate platelet aggregation during arterial thrombosis in vivo 14,15 , and clotting in extracorporeal devices usually occurs at sites of sudden flow disturbances, stagnation points and stenosed sections of tubing 16,17 .”
Cited by
Point-of-Care Diagnostics: Recent Developments in a Connected Age
Nayak, S., Blumenfeld, N. R., Laksanasopin, T., & Sia, S. K. (2017) · Analytical Chemistry · doi:10.1021/acs.analchem.6b04630 · Cited by 508
Shrivastava, S., Trung, T. Q., & Lee, N.-E. (2020) · Chemical Society Reviews · doi:10.1039/c9cs00319c · Cited by 497
Jain, A., Barrile, R., van der Meer, A., Mammoto, A., Mammoto, T., De Ceunynck, K., Aisiku, O., Otieno, M., Louden, C., Hamilton, G., et al. (2018) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.742 · Cited by 325
“Additionally, we found that this PBD index increased when we raised the hemodynamic shear rate from 275 s to 750 s in the microfluidic channel (by altering pumping rates), indicating a higher tendency to form platelet-rich thrombi and promote platelet-endothelial binding interactions in vitro (Figure 2d), as reported…”
ResultSelf-citationShear-Dependent Platelet Aggregation: Mechanisms and Therapeutic Opportunities
Rana, A., Westein, E., Niego, B., & Hagemeyer, C. E. (2019) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2019.00141 · Cited by 226
SERS-based microdevices for use as in vitro diagnostic biosensors
Lee, S., Dang, H., Moon, J.-I., Kim, K., Joung, Y., Park, S., Yu, Q., Chen, J., Lu, M., Chen, L., et al. (2024) · Chemical Society Reviews · doi:10.1039/d3cs01055d · Cited by 220
Metadata
- Authors
- Jain, A., Graveline, A., Waterhouse, A., Vernet, A., Flaumenhaft, R., & Ingber, D. E.
- Affiliations
- Boston Children's Hospital (US)
- Harvard University (US)
- Beth Israel Deaconess Medical Center (US)
- Corresponding author
- Ingber, Donald E.
- ORCID
- Venue
- Nature Communications
- Published
- 2016-01-06
- Volume
- 7
- Issue
- 1
- Pages
- 10176-10176
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC4729824
- OpenAlex
- W2343360984
- Cited by
- 182
- References
- 47
- Citations by year
- 2026: 8 · 2025: 16 · 2024: 20 · 2023: 18 · 2022: 12 · 2021: 14 · 2020: 28 · 2019: 22 · 2018: 15 · 2017: 18 · 2016: 11
- FWCI
- 19.66
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Nature Communications (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Science Foundation (ECS- 03-35765, 0335765)
- Harvard University (ECS-0335765)
- National Institutes of Health (ECS-0335765)
- Defense Advanced Research Projects Agency (N66001‐11‐1‐4180, HR0011, HR0011-13-C-0025)
- Hansjörg Wyss Institute for Biologically Inspired Engineering, Harvard University
- National Heart, Lung, and Blood Institute (R01HL125275, R01HL112809, T32HL007917)
- Topics
- Health Sciences › Medicine › Hematology › Blood properties and coagulation
- Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
- Health Sciences › Medicine › Hematology › Platelet Disorders and Treatments
- Keywords
- platelet function, microfluidics, shear gradient, thrombus formation, coagulation, extracorporeal circuit, anticoagulation, heparin, endotoxemia, coagulopathy, personalized diagnosis
- MeSH terms
- Abciximab, Animals, Antibodies, Monoclonal, Blood Coagulation Tests, Blood Platelets, Female, Hemostasis, Humans, Immunoglobulin Fab Fragments, Platelet Aggregation, Platelet Aggregation Inhibitors, Platelet Function Tests, Swine, Point-of-Care Systems, Shear Strength, Microfluidic Analytical Techniques, Lab-On-A-Chip Devices
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.